PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV · News & media

Explainer | Eli Lilly’s Mounjaro Enters India | Price, Dose & Everything You Need To Know

News & media9:55Mar 2025

Today’s cheapest tirzepatide$69/mo at Wellmedr, sale price.Compare all tirzepatide prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

According to the video, the channel explainer, Eli Lilly has launched Mounjaro in India after approval from the country's Central Drug Standards Control Organisation. The presenter describes it as a weekly injection for obesity and type 2 diabetes, and says demand in India had been anticipated for some time.

Published by Business Today on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

On price, the video reports figures given by company spokespersons: a 2.5 mg vial at 3,500 rupees and a 5 mg vial at 4,375 rupees. The presenter says this works out to roughly 14,000 to 17,000 rupees a month for weekly use, depending on a doctor's recommendation, and contrasts it with a US price of 86,000 rupees to 1 lakh per month. The video also describes Mounjaro as the first drug to activate both GIP and GLP-1 receptors, and cites company claims from a 72 week trial of weight loss of up to 21.8 kg at the 15 mg dose and 15.4 kg at the 5 mg dose.

The presenter also covers the Indian market, saying Novo Nordisk's semaglutide-based Rybelsus holds 65% of the anti-obesity market. Lilly's dosing guidance, as relayed, starts at 2.5 mg weekly and rises by 2.5 mg every 4 weeks to a maximum of 15 mg, with maintenance doses of 5 mg, 10 mg or 15 mg injected under the skin. The company lists nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and abdominal pain as the most common side effects. It says the drug will be available in registered pharmacies with a valid prescription within weeks.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:14 Eli Lilly has launched Mounjaro in India as a weekly injection for obesity and type 2 diabetes after CDSCO approval.
  2. 1:16 Company spokespersons gave prices of 3,500 rupees for the 2.5 mg vial and 4,375 rupees for the 5 mg vial, or about 14,000 to 17,000 rupees a month.
  3. 2:18 The video describes Mounjaro as the first drug to activate both GIP and GLP-1 receptors, and cites up to 21.8 kg weight loss at 15 mg in a 72 week trial.
  4. 5:55 The company says the drug will reach India in weeks, and lists nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and abdominal pain as common side effects.
  5. 7:07 The stated regimen starts at 2.5 mg weekly, rises by 2.5 mg every 4 weeks, and tops out at 15 mg weekly.
  6. 8:01 Mounjaro will be sold in registered pharmacies with a valid prescription in the coming weeks.

Key moments

Tap one to play from there.

  1. 0:00 Mounjaro launch in India
  2. 1:14 Pricing and market demand
  3. 2:27 Mechanism and clinical trial
  4. 4:16 Indian market opportunity
  5. 5:55 Dosage and side effects
  6. 8:09 Future market outlook

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Mounjaro and semaglutide

Questions this video answers

How much does Mounjaro cost in India?

According to the video, company spokespersons priced the 2.5 mg vial at 3,500 rupees and the 5 mg vial at 4,375 rupees. The presenter says this comes to about 14,000 to 17,000 rupees a month for weekly use, depending on the doctor's recommendation.

What is the Mounjaro dosing schedule in India?

The video relays the company's regimen: start at 2.5 mg once weekly and increase by 2.5 mg every 4 weeks up to a maximum of 15 mg weekly. Maintenance doses are given as 5 mg, 10 mg or 15 mg injected under the skin once weekly.

What are the side effects of Mounjaro according to Eli Lilly?

The company says the most common side effects are nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and abdominal pain. It adds that these are similar to other GLP-1 receptor agonists already sold in India, and that no unusual side effects were mentioned.

How can you get Mounjaro in India?

The video says Mounjaro will be available in registered pharmacies with a valid prescription in the coming weeks. A company spokesperson told the channel it would arrive in weeks.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Zepbound vs Mounjaro: one molecule, two labels, and why the label sets your price

    Zepbound and Mounjaro are both tirzepatide, made by Lilly, injected weekly at the same six doses from 2.5 to 15 mg. Mounjaro is approved for type 2 diabetes and Lilly's own site says it is not a weight-loss drug; Zepbound is the same molecule approved for obesity and sleep apnoea. That label decides everything downstream: insurers cover Mounjaro for diabetes and refuse it for weight, Zepbound is the box a plan can cover for weight, and Zepbound's cash price runs $299 to $699 by dose, while LillyDirect sells Mounjaro from $499 a month at every strength, against a list price of $1,112.16 per fill.

  • Mounjaro dosage chart: the label's schedule, every pen and vial, and what each dose costs

    Mounjaro starts at 2.5 mg injected once a week. If more blood sugar control is needed, the dose goes up in 2.5 mg steps after at least four weeks on the current dose, to a maximum of 15 mg a week for adults and 10 mg for children 10 and older. Lilly sells every strength self-pay starting at $499 a month, so on the brand the price does not climb with the dose.

  • Mounjaro for weight loss, and why Zepbound exists

    Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.

Next steps

Mounjaro prices

Insurance

Find more like it

Side effectsDose changeCost and insuranceHow it works

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV